Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.See previous edition Psychedelics Headlines: A Form Of Life, Treati
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the last two weeks of March 2024.See previous edition Psychedelics Headlines: Substitution Survey, Fr
Red Light Holland Announces That MISTERCAP'S Mushroom Home Grow Kits Selected by Urban Outfitters for Nationwide Retail Distribution in the USA
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private PlacementClinical-stage psychedelics biopharma c
Red Light Holland Announces Happy Caps Mushroom Home Grow Kits Now Available in Over 270 Retail Stores Across Canada
Truffles To Market: Red Light Holland Wants To Develop Psilocybin API At Scale
Research and regulatory collaboration between Canadian biotechs Red Light Holland (OTCQB:TRUFF) and PharmAla (OTC:MDXXF) is bearing fruit. The partners are moving forward with a new project to bring A
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized AnxietyPsilocybin-assisted therapy has hit a milestone as clinical trial results show potential benefits f
Earnings Call Summary | RED LIGHT HOLLAND CORP(TRUFF.US) Q3 2024 Earnings Conference
The following is a summary of the Red Light Holland Corp. (TRUFF) Q3 2024 Earnings Call Transcript:Financial Performance:Red Light Holland reported Q3 revenue of $1.3 million, a growth of 9.9% over th
Red Light Holland Exports Psilocybin For Research, Microdosing Capsules And More News From This Dutch Company
Montreal-based GMP pharmaceutical laboratory CCrest Labs, an R&D collaborator of Ontario-based mushroom company Red Light Holland Corp. (OTCQB:TRUFF), has received a fifth psilocybin import permit to
Red Light Holland Provides Timing for Release of Third Quarter Financial Results and Announces Live QA
CSE Bulletin: Expiry - Red Light Holland Corp. 24FEB2024 Warrants (TRIP.WT.A)
Toronto, Ontario--(Newsfile Corp. - le 20 février/February 2024) - Red Light Holland Corp. 24FEB2024 Warrants listed on February 24, 2021 will expire on February 24, 2024. Settlement Terms: All trade
PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development
Red Light Holland's Homogenized Psilocybin Microdosing Capsules Complete Product Specification Document by CGMP Pharmaceutical Company CCrest Laboratories, Provided to NUBU Pharmaceuticals in Australasia
Red Light Holland Receives Building Permit for AEM Farms 80,000 Square Foot Mushroom Farm, Adding Substantial Future Production Capacity
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Defense Dept. Funds Ketamine Study For PTSD Treatment A DOD Health Agency-funded adaptive platform trial for alternative treatments for PTSD will test SLS-002 on some 600 active-duty service members
Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company?
Ontario-based Canadian psychedelics company Braxia Scientific Corp. (OTC:BRAXF) filed its interim financial statements and management discussion for the three and six months ended Sept. 30, 2023. Num
Red Light Holland, With $12M Cash Balance & Revenue Up 33%, Remains 'Confident' In Business Strategy
Canada-based all-mushroom producer Red Light Holland Corp. (OTCQB:TRUFF) filed its quarterly financial statements and management discussion and analysis for the three and six months ended Sept. 30, 20
Red Light Holland Reports Q2 Results
U.S. Patent For 3D Movement Data Goes To Red Light Holland Subsidiary, More AI Innovation Ahead
Canadian mushrooms producer Red Light Holland's (OTCQB:TRUFF) wholly-owned tech subsidiary Radix Motion received a U.S. patent grant for the use of human movement data in psychedelic-assisted therapy
Red Light Holland's Fully Owned Subsidiary, Radix Motion, Granted Patent for 3D Movement Data and AI Innovations
Radix Motion, a fully-owned technology subsidiary of Red Light Holland Corp. (OTCQB: TRUFF) is pleased to announce that further to its press release dated June 1, 2023, its U.S. "continuation-in-part" (CIP) application, which was granted the right to participate in the "Patent Prosecution Highway" program, has been granted and received the patent number: 11,806,16.
No Data